Incomplete stent apposition and uncovered struts are associated with a higher risk of stent thrombosis. No data exist on the process of neointimal coverage and late apposition status of the bioresorbable vascular scaffold (BVS) when implanted in the highly thrombogenic setting of ST-segment elevation acute myocardial infarction (STEMI). The aim of this study was to assess the serial changes in strut apposition and early neointimal coverage of the BVS using optical coherence tomography (OCT) in selected patients enrolled in the PRAGUE-19 study. Intracoronary OCT was performed in 50 patients at the end of primary percutaneous coronary intervention for acute STEMI. Repeated OCT of the implanted BVS was performed in 10 patients. Scaffold area, scaffold mean diameter and incomplete strut apposition (ISA) were compared between baseline and control OCT. Furthermore, strut neointimal coverage was assessed during the control OCT. Mean scaffold area and diameter did not change between the baseline and control OCT (8.59 vs. 9.06 mm(2); p = 0.129 and 3.31 vs. 3.37 mm; p = 0.202, respectively). Differences were observed in ISA between the baseline and control OCT (0.63 vs. 1.47 %; p < 0.05). We observed 83.1 % covered struts in eight patients in whom the control OCT was performed 4-6 weeks after BVS implantation, and 100 % covered struts in two patients 6 months after BVS implantation. Persistent strut apposition and early neointimal coverage were observed after biodegradable vascular scaffold implantation in patients with acute ST-segment elevation myocardial infarction.

1st Faculty of Medicine Cardiovascular Center Charles University Prague Central Military Hospital Prague Prague Czech Republic

3rd Faculty of Medicine Cardiocenter Charles University Prague University Hospital Kralovske Vinohrady Ruska 87 100 00 Prague Czech Republic

See more in PubMed

Eur Heart J. 2014 Mar;35(12):777-86 PubMed

Heart Vessels. 2013 Jul;28(4):424-33 PubMed

Circ Cardiovasc Interv. 2011 Oct 1;4(5):535-8 PubMed

EuroIntervention. 2015 Apr;10(12):1396-401 PubMed

Heart Vessels. 2014 May;29(3):320-7 PubMed

Eur Heart J. 2014 Mar;35(12):753-7 PubMed

Int J Cardiol. 2013 Jan 20;162(3):166-71 PubMed

JACC Cardiovasc Interv. 2011 Sep;4(9):992-1001 PubMed

EuroIntervention. 2014 Jan 22;9(9):1036-41 PubMed

EuroIntervention. 2014 Mar 20;9(11):1271-84 PubMed

Circulation. 2010 Nov 30;122(22):2301-12 PubMed

J Am Coll Cardiol. 2014 Apr 15;63(14 ):1355-67 PubMed

Circ Cardiovasc Interv. 2012 Oct;5(5):620-32 PubMed

Eur Heart J. 2014 Mar;35(12):787-94 PubMed

JACC Cardiovasc Interv. 2011 Dec;4(12):1271-80 PubMed

EuroIntervention. 2013 Aug 22;9(4):501-4 PubMed

Bioresorbable scaffold implantation in STEMI patients: 5 years imaging subanalysis of PRAGUE-19 study

Immune-inflammatory response after bioresorbable vascular scaffold implantation in patients with acute myocardial infarction with ST elevation in a long-term perspective